Wexford Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-17,389
| Closed | -$1.01M | – | 230 |
|
|
2023
Q3 | $1.01M | Hold |
17,389
| – | – | 0.22% | 71 |
|
|
2023
Q2 | $1.11M | Hold |
17,389
| – | – | 0.22% | 69 |
|
|
2023
Q1 | $1.21M | Buy |
+17,389
| New | +$1.21M | 0.25% | 61 |
|
|
2021
Q1 | – | Sell |
-2,361
| Closed | -$146K | – | 217 |
|
|
2020
Q4 | $146K | Sell |
2,361
-78,697
| -97% | -$4.87M | 0.02% | 155 |
|
|
2020
Q3 | $4.89M | Sell |
81,058
-108,970
| -57% | -$6.57M | 1.31% | 21 |
|
|
2020
Q2 | $11.2M | Buy |
190,028
+117,152
| +161% | +$6.89M | 2.81% | 8 |
|
|
2020
Q1 | $4.06M | Buy |
+72,876
| New | +$4.06M | 1.5% | 18 |
|
|
2019
Q1 | – | Sell |
-150,315
| Closed | -$7.81M | – | 95 |
|
|
2018
Q4 | $7.81M | Buy |
+150,315
| New | +$7.81M | 0.67% | 23 |
|